Advertisement

Topics

EU CHMP To Review July Rejection Of Drugs For Schizophrenia, Metastatic Breast Cancer

05:41 EST 8 Nov 2017 | Elsevier Business Intelligence

The EMA’s CHMP is this week hearing oral evidence on two products it turned down in July – for schizophrenia... ...

Original Article: EU CHMP To Review July Rejection Of Drugs For Schizophrenia, Metastatic Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "EU CHMP To Review July Rejection Of Drugs For Schizophrenia, Metastatic Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Hearing
Hearing, auditory perception, or audition is the ability to perceive sound by detecting vibrations, changes in the pressure of the surrounding medium through time, through an organ such as the ear. Sound may be heard through solid, liquid, or gaseous mat...

Schizophrenia
Schizophrenia is a common  serious long-term mental health condition that affects 5 in 1000 in the UK. It causes a range of different psychological symptoms; hallucinations, delusions, muddled thoughts based on the hallucinations or delusions and ch...